Daniyal Hussain

Daniyal Hussain is an experienced professional in technology business development and innovation within the pharmaceutical industry. Currently serving as Executive Director at GSK since August 2023, Daniyal previously held the position of Senior Director of Innovation at Valo from May 2019 to August 2023 and served as Director. Prior experience includes an Associate Director role in immuno-oncology at AstraZeneca, where responsibilities encompassed global product forecasting and clinical strategy. Daniyal's career also includes a managerial role at Huron Consulting Group, focusing on project management and strategic analysis for pharmaceutical firms and healthcare investors, alongside consulting at Frankel Group from 2009 to 2013. Daniyal Hussain holds an MBA from Columbia Business School and a Master of Public Health in Healthcare Management from Columbia University Mailman School of Public Health, complemented by a dual bachelor's degree in Chemical and Biomolecular Engineering and Economics from the University of Pennsylvania.